Article thumbnail

Common Inherited Variation in Mitochondrial Genes Is Not Enriched for Associations with Type 2 Diabetes or Related Glycemic Traits

By Ayellet V. Segrè, , , Leif Groop, Vamsi K. Mootha, Mark J. Daly and David Altshuler

Abstract

Mitochondrial dysfunction has been observed in skeletal muscle of people with diabetes and insulin-resistant individuals. Furthermore, inherited mutations in mitochondrial DNA can cause a rare form of diabetes. However, it is unclear whether mitochondrial dysfunction is a primary cause of the common form of diabetes. To date, common genetic variants robustly associated with type 2 diabetes (T2D) are not known to affect mitochondrial function. One possibility is that multiple mitochondrial genes contain modest genetic effects that collectively influence T2D risk. To test this hypothesis we developed a method named Meta-Analysis Gene-set Enrichment of variaNT Associations (MAGENTA; http://www.broadinstitute.org/mpg/magenta). MAGENTA, in analogy to Gene Set Enrichment Analysis, tests whether sets of functionally related genes are enriched for associations with a polygenic disease or trait. MAGENTA was specifically designed to exploit the statistical power of large genome-wide association (GWA) study meta-analyses whose individual genotypes are not available. This is achieved by combining variant association p-values into gene scores and then correcting for confounders, such as gene size, variant number, and linkage disequilibrium properties. Using simulations, we determined the range of parameters for which MAGENTA can detect associations likely missed by single-marker analysis. We verified MAGENTA's performance on empirical data by identifying known relevant pathways in lipid and lipoprotein GWA meta-analyses. We then tested our mitochondrial hypothesis by applying MAGENTA to three gene sets: nuclear regulators of mitochondrial genes, oxidative phosphorylation genes, and ∼1,000 nuclear-encoded mitochondrial genes. The analysis was performed using the most recent T2D GWA meta-analysis of 47,117 people and meta-analyses of seven diabetes-related glycemic traits (up to 46,186 non-diabetic individuals). This well-powered analysis found no significant enrichment of associations to T2D or any of the glycemic traits in any of the gene sets tested. These results suggest that common variants affecting nuclear-encoded mitochondrial genes have at most a small genetic contribution to T2D susceptibility

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2920848
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2009). (n.d.) The polymorphisms of UCP1 genes associated with fat metabolism, obesity and diabetes. Molecular Biology Reports, Available: http://dx.doi.org.ezp-prod1.hul.harvard.edu/10.1007/ s11033-009-9550-2.
  2. (2005). A fine-scale map of recombination rates and hotspots across the human genome.
  3. (2007). A genomewide association study of type 2 diabetes in Finns detects multiple susceptibility variants.
  4. (2005). A map of the human genome in linkage disequilibrium units.
  5. (2008). A mitochondrial protein compendium elucidates complex I disease biology.
  6. (2009). Activation of PPARdelta upregulates fatty acid oxidation and energy uncoupling genes of mitochondria and reduces palmitate-induced apoptosis in pancreatic beta-cells.
  7. (2005). Alternative splicing of human insulin-degrading enzyme yields a novel isoform with a decreased ability to degrade insulin and amyloid beta-protein.
  8. (1995). Biometry: The principles and Practice of Statistics in Biological Research. Third Edition.
  9. (2007). Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs.
  10. (2009). Common polygenic variation contributes to risk of schizophrenia and bipolar disorder.
  11. (2004). Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial.
  12. (2009). Common variants at 30 loci contribute to polygenic dyslipidemia.
  13. (2006). Comprehensive association testing of common mitochondrial DNA variation in metabolic disease.
  14. (2009). Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease.
  15. (2002). Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes.
  16. (2004). Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle.
  17. (2010). Gene and pathway-based second-wave analysis of genome-wide association studies.
  18. (2000). Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.
  19. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
  20. (2009). Genetic association analysis of 13 nuclear-encoded mitochondrial candidate genes with type II diabetes mellitus: the DAMAGE study.
  21. (2009). Genetic determinants and molecular pathways in the pathogenesisofType2 diabetes.
  22. (2007). Genetic factors related to mitochondrial function and risk of diabetes mellitus.
  23. (2003). Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits.
  24. (2010). Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge.
  25. (2007). Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.
  26. (2009). GLOSSI: a method to assess the association of genetic loci-sets with complex diseases.
  27. Heilbronn LK (2008) Is mitochondrial dysfunction a cause of insulin resistance?
  28. (2008). High-resolution mapping of expression-QTLs yields insight into human gene regulation.
  29. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
  30. (2004). Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes.
  31. (2009). Interrogating type 2 diabetes genome-wide association data using a biological pathway-based approach.
  32. (2009). Is skeletal muscle mitochondrial dysfunction a cause or an indirect consequence of insulin resistance in humans?
  33. (2008). Metaanalysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes.
  34. (2009). Mitochondria and diabetes mellitus: untangling a conflictive relationship?
  35. (2005). Mitochondrial DNA mutations in human disease.
  36. (2005). Mitochondrial dysfunction and type 2 diabetes.
  37. (2010). New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.
  38. (2008). On the utility of gene set methods in genomewide association studies of quantitative traits.
  39. (2003). PANTHER: A Library of Protein Families and Subfamilies Indexed by Function.
  40. (2009). Pathway and network-based analysis of genome-wide association studies in multiple sclerosis.
  41. (2007). Pathway-Based Approaches for Analysis of Genomewide Association Studies.
  42. (2006). PGC-1 coactivators: inducible regulators of energy metabolism in health and disease.
  43. (2003). PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes.
  44. (2003). Regulation and co-ordination of nuclear gene expression during mitochondrial biogenesis.
  45. (2007). Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.
  46. (2009). SIRT1 and insulin resistance.
  47. (2009). Strategies and issues in the detection of pathway enrichment in genome-wide association studies.
  48. (2009). The coordination of nuclear and mitochondrial communication during aging and calorie restriction.
  49. (2004). The future of association studies: gene-based analysis and replication.
  50. (2009). The role of sirtuins in the control of metabolic homeostasis.
  51. (2008). Transcriptional control of energy homeostasis by the estrogenrelated receptors.
  52. (2004). Transcriptional regulatory circuits controlling mitochondrial biogenesis and function.
  53. (2010). Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nature Genetics,
  54. (2009). Using genome-wide pathway analysis to unravel the etiology of complex diseases.